跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lecarpone - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lecarpone
Approved
STANDARD
Lecarpone
Baroque Pharmaceuticals Pvt. Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
eb3874e24c048dc2
Company
Baroque Pharmaceuticals Pvt. Ltd
Type
Standard
Approval Details
Approval Id
eb3874e24c048dc2
Drug Approval Philippines Name
Lecarpone
Product Name
Lecarpone
Registration Number
DRP-15832
Brand Name
Lecarpone
Generic Name
Levodopa + Carbidopa (as monohydrate) + Entacapone
Dosage Form
Film Coated Tablet
Dosage Strength
100 mg/25 mg/200 mg
Manufacturer
Baroque Pharmaceuticals Pvt. Ltd
Issuance Date
24 September 2024
Expiry Date
24 September 2029
Pharmacologic Category
Anti-Parkinson Drug (Dopaminergic Agent)
Classification
Prescription (Rx) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
eb3874e24c048dc2
Type
Standard
Back to Philippines FDA Approvals